Microsynth Releases Q3 Newsletter with Service Updates
Microsynth has published its Q3 2026 newsletter, detailing new services and improvements for sequencing projects, including direct submission of E. coli liquid cultures.
Microsynth, a biotechnology company, released its third quarter (Q3) 2026 newsletter on October 2, 2026. The publication outlines new services and enhancements aimed at streamlining sequencing projects for clients, from sample submission to data analysis.
Effective October 5, 2026, customers will be able to submit E. coli liquid cultures directly for the Full PlasmidSeq service. Microsynth will manage the plasmid preparation process, a move intended to reduce client workload and expedite project timelines.
The company is also introducing redesigned Amplicon Metagenomics reports, which feature improved data presentation and analysis. Additionally, the newsletter provides access to recordings of recent webinars covering relevant topics in biotechnology.
Microsynth is encouraging customer feedback through a survey included in the newsletter, seeking input to guide future service development. The full newsletter is available for review online.